Exact Sciences
EXAS
#1766
Rank
โ‚ฌ8.88 B
Marketcap
48,00ย โ‚ฌ
Share price
-3.29%
Change (1 day)
-13.94%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ2.57 Billion

According to Exact Sciences's latest financial reports the company's total debt is โ‚ฌ2.57 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Exact Sciences - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ2.31 B1.31%
2022-12-31โ‚ฌ2.28 B8.45%
2021-12-31โ‚ฌ2.10 B11.01%
2020-12-31โ‚ฌ1.89 B122.26%
2019-12-31โ‚ฌ0.85 B41.5%
2018-12-31โ‚ฌ0.60 B16141.42%
2017-12-31โ‚ฌ3.7 M-28.96%
2016-12-31โ‚ฌ5.22 M-5.09%
2015-12-31โ‚ฌ5.5 M125.01%
2014-12-31โ‚ฌ2.44 M-22.65%
2013-12-31โ‚ฌ3.16 M104.59%
2012-12-31โ‚ฌ1.54 M100.67%
2011-12-31โ‚ฌ0.77 M2.42%
2010-12-31โ‚ฌ0.75 M-45.82%
2009-12-31โ‚ฌ1.38 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ0.13 B-94.80%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.36 M-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.8 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ23.73 B 823.03%๐Ÿ‡ซ๐Ÿ‡ท France